Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA gives FSD Pharma permission to submit IND for phase IIa trial of FSD-201 for COVID-19

June 4, 2020

Phase II data reported from TreeTopp study of varlitinib plus capecitabine in BTC

June 4, 2020

Rgenix presents monotherapy dose-escalation data from phase I study of RGX-202

June 4, 2020

First patient data presented for PF-06804103 antibody-drug conjugate

June 4, 2020

Brukinsa receives approval in China for patients with CLL/SLL and MCL

June 4, 2020

FDA accepts IND for phase I/II trial of Treadwell's HPK1 inhibitor CFI-402411

June 4, 2020

A new ASK1 inhibitor presenting brain penetration

June 4, 2020

Identification of a JAK inhibitor selectively targeting GI tissues for inflammatory bowel disease

June 4, 2020

Estrogen and dopamine

June 4, 2020

iPSC microtissue gives clues to heart disease

June 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...